NASDAQ:ABVC - Nasdaq - US00091F3047 - Common Stock - Currency: USD
Taking everything into account, ABVC scores 1 out of 10 in our fundamental rating. ABVC was compared to 551 industry peers in the Biotechnology industry. ABVC has a bad profitability rating. Also its financial health evaluation is rather negative. ABVC has a expensive valuation and it also scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -12.18% | ||
ROE | -33.53% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 99.92% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.15 | ||
Debt/FCF | N/A | ||
Altman-Z | -4.61 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.22 | ||
Quick Ratio | 0.22 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
2.7
+0.08 (+3.05%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 89.06 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 8.38 | ||
P/tB | 8.38 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -12.18% | ||
ROE | -33.53% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 99.92% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.15 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.22 | ||
Quick Ratio | 0.22 | ||
Altman-Z | -4.61 |